Rothenberg ML - Search Results

1

Intraperitoneal therapy for stage III ovarian cancer: a therapy whose time has come!

Alberts DS, Markman M, Armstrong D, Rothenberg ML, Muggia F, Howell SB. Alberts DS, et al. Among authors: rothenberg ml. J Clin Oncol. 2002 Oct 1;20(19):3944-6. doi: 10.1200/JCO.2002.20.19.3944. J Clin Oncol. 2002. PMID: 12351590 No abstract available.

2

Dose-intensive induction therapy with cyclophosphamide, cisplatin, and consolidative abdominal radiation in advanced-stage epithelial ovarian cancer.

Rothenberg ML, Ozols RF, Glatstein E, Steinberg SM, Reed E, Young RC. Rothenberg ML, et al. J Clin Oncol. 1992 May;10(5):727-34. doi: 10.1200/JCO.1992.10.5.727. J Clin Oncol. 1992. PMID: 1569445 Clinical Trial.

3

High-dose carboplatin and recombinant granulocyte-macrophage colony-stimulating factor in advanced-stage recurrent ovarian cancer.

Reed E, Janik J, Bookman MA, Rothenberg M, Smith J, Young RC, Ozols RF, VanderMolen L, Kohn E, Jacob JL, et al. Reed E, et al. J Clin Oncol. 1993 Nov;11(11):2118-26. doi: 10.1200/JCO.1993.11.11.2118. J Clin Oncol. 1993. PMID: 8229126

4

Phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer: a Southwest Oncology Group trial (SWOG-9326).

Rothenberg ML, Liu PY, Wilczynski S, Hannigan EV, Weiner SA, Weiss GR, Hunter VJ, Chapman JA, Tiersten A, Kohler PC, Alberts DS. Rothenberg ML, et al. Gynecol Oncol. 2001 Aug;82(2):317-22. doi: 10.1006/gyno.2001.6274. Gynecol Oncol. 2001. PMID: 11531286 Clinical Trial.

5

Combined intraperitoneal and intravenous chemotherapy for women with optimally debulked ovarian cancer: results from an intergroup phase II trial.

Rothenberg ML, Liu PY, Braly PS, Wilczynski SP, Hannigan EV, Wadler S, Stuart G, Jiang C, Markman M, Alberts DS. Rothenberg ML, et al. J Clin Oncol. 2003 Apr 1;21(7):1313-9. doi: 10.1200/JCO.2003.07.031. J Clin Oncol. 2003. PMID: 12663720 Clinical Trial.

6

Long-term follow-up of a phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer in the Southwest Oncology Group.

Alberts DS, Jiang C, Liu PY, Wilczynski S, Markman M, Rothenberg ML. Alberts DS, et al. Among authors: rothenberg ml. Int J Gynecol Cancer. 2004 Mar-Apr;14(2):224-8. doi: 10.1111/j.1048-891X.2004.014204.x. Int J Gynecol Cancer. 2004. PMID: 15086720

7

Phase II trial of vinorelbine for relapsed ovarian cancer: a Southwest Oncology Group study.

Rothenberg ML, Liu PY, Wilczynski S, Nahhas WA, Winakur GL, Jiang CS, Moinpour CM, Lyons B, Weiss GR, Essell JH, Smith HO, Markman M, Alberts DS. Rothenberg ML, et al. Gynecol Oncol. 2004 Dec;95(3):506-12. doi: 10.1016/j.ygyno.2004.09.004. Gynecol Oncol. 2004. PMID: 15581954 Clinical Trial.

8

Pretreatment CA-125 and risk of relapse in advanced ovarian cancer.

Markman M, Liu PY, Rothenberg ML, Monk BJ, Brady M, Alberts DS. Markman M, et al. Among authors: rothenberg ml. J Clin Oncol. 2006 Mar 20;24(9):1454-8. doi: 10.1200/JCO.2005.04.7373. J Clin Oncol. 2006. PMID: 16549840

9

Intraperitoneal chemotherapy for ovarian cancer: overview and perspective.

Rao G, Crispens M, Rothenberg ML. Rao G, et al. Among authors: rothenberg ml. J Clin Oncol. 2007 Jul 10;25(20):2867-72. doi: 10.1200/JCO.2007.10.8167. J Clin Oncol. 2007. PMID: 17617517 Review.

10

The role of nonrandomized trials in the evaluation of oncology drugs.

Simon R, Blumenthal GM, Rothenberg ML, Sommer J, Roberts SA, Armstrong DK, LaVange LM, Pazdur R. Simon R, et al. Among authors: rothenberg ml. Clin Pharmacol Ther. 2015 May;97(5):502-7. doi: 10.1002/cpt.86. Epub 2015 Apr 7. Clin Pharmacol Ther. 2015. PMID: 25676488

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

150 results

Search Page

Filters